Vasospasm and statin therapy: yet another cautionary tale.
Rabinstein
Alejandro A
AA
Division of Critical Care Neurology, Department of Neurology, W8B, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. rabinstein.alejandro@mayo.edu
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015995:Prevalence; D020301:Vasospasm, Intracranial / Q000188:drug therapy* / Q000453:epidemiology
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
Stroke. 2007 May;38(5):1545-50
17413047
Stroke. 2002 Dec;33(12):2950-6
12468796
J Neurosurg. 2007 Dec;107(6):1092-100
18077945
Stroke. 2005 Aug;36(8):1627-32
16049199
Neurosurgery. 2008 Feb;62(2):422-7; discussion 427-30
18382320
J Neurosurg. 2006 Nov;105(5):671-4
17121126
Ann Pharmacother. 2007 Dec;41(12):2019-23
17986515
J Neurosurg. 2009 May;110(5):968-74
19199459
J Neurosci Res. 2008 Dec;86(16):3635-43
18683242
Stroke. 2008 Sep;39(9):2622-6
18658040
Surg Neurol. 2009 Mar;71(3):311-7, discussion 317-8
18423529
Stroke. 2005 Sep;36(9):2024-6
16051891
Neurosurgery. 2006 May;58(5):945-51; discussion 945-51
16639331
Stroke. 2008 Oct;39(10):2891-3
18658043
Neurol Res. 2008 Nov;30(9):893-7
18691455
J Clin Neurosci. 2009 Apr;16(4):527-30
19231192
Trends Mol Med. 2008 Jan;14(1):37-44
18068482
BMC Neurosci. 2009 Jan 21;10:7
19159448
Neurology. 2005 Mar 22;64(6):1008-13
15781818
Neurosurgery. 2005 Mar;56(3):476-84; discussion 476-84
15730572
J Cereb Blood Flow Metab. 2009 Aug;29(8):1444-53
19458605